Fundraising FoxBioluminescence Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
GEMMABiogemmabiotx.comDec 2024 · $34M
GEMMABio is a biotechnology company developing gene therapies for rare diseases using next-generation AAV technology, with programs spanning motor neuron disorders and skeletal and cardiomyopathies.
BiotechHealthtechPhiladelphia, US
James M. Wilson(Founder)
Co-investorsIKJ CapitalEarlybird Venture Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.